US 12240816
Deuterated compounds and uses thereof
granted A61KA61K31/47A61K45/06
Quick answer
US patent 12240816 (Deuterated compounds and uses thereof) held by Aldeyra Therapeutics, Inc. expires Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aldeyra Therapeutics, Inc.
- Grant date
- Tue Mar 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/47, A61K45/06, A61P, A61P17/00